Summary from ASCO 2020 virtual meeting
This article nicely summarises the most exciting research highlights from [...]
Re-treatment with immune checkpoint inhibitors in kidney cancer patients
Immune checkpoint inhibitor combinations for the treatment of patients with [...]
Impact of delay in surgery or time to surgery on kidney cancer outcomes
A recent study published in the Journal of Urology this [...]
Neutrophil-lymphocyte ratio as a prognostic biomarker in high-risk locally advanced kidney cancer
An analysis of the data collected during the S-TRAC study, [...]
Activity of cabozantinib after immunotherapy in advance kidney cancer
A retrospective study published in the European Journal of Cancer [...]
Inflammatory biomarkers to predict outcomes in kidney cancer
There still remains the need for a reliable biomarker to [...]
Surgical treatment of inferior vena cava tumour thrombi in kidney cancer
The formation of a cancerous blood clot, or thrombus, in [...]
Potential biomarker for response to nivolumab for kidney cancer
Nivolumab was the first immunotherapy to be approved for the [...]
Potential screening blood test for early kidney cancer
Researchers at the Dana-Farber Cancer Institute in Boston, USA have [...]
New targeted therapy shows potential for previously treated metastatic kidney cancer
A phase II study published in Frontiers in Oncology last [...]
